Abstract
Patients with atrial fibrillation (AF) may require cardiac implantable electronic devices (CIEDs). However, limited data are available on the use of oral factor Xa inhibitors in patients receiving CIEDs. ROCKET AF randomized 14,264 patients with nonvalvular AF to warfarin or rivaroxaban. We
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
